[HTML][HTML] Obesogenic medications and weight gain over 24 weeks in patients with depression: results from the GUIDED study

JG Fiedorowicz, L Brown, J Li, SV Parikh… - Psychopharmacology …, 2021 - ncbi.nlm.nih.gov
Weight gain is a common side-effect of medications used to treat major depressive disorder
(MDD). We sought to estimate the frequency of weight gain for obesogenic medications …

Obesogenic Medications and Weight Gain Over 24 Weeks in Patients with Depression: Results from the GUIDED Study.

JG Fiedorowicz, L Brown, J Li, SV Parikh… - Psychopharmacology …, 2021 - europepmc.org
Weight gain is a common side-effect of medications used to treat major depressive disorder
(MDD). We sought to estimate the frequency of weight gain for obesogenic medications …

Obesogenic Medications and Weight Gain Over 24 Weeks in Patients with Depression: Results from the GUIDED Study

JG Fiedorowicz, L Brown, J Li, SV Parikh… - Psychopharmacology …, 2021 - iro.uiowa.edu
Weight gain is a common side-effect of medications used to treat major depressive disorder
(MDD). We sought to estimate the frequency of weight gain for obesogenic medications …

Obesogenic Medications and Weight Gain Over 24 Weeks in Patients with Depression: Results from the GUIDED Study

JG Fiedorowicz, L Brown, J Li… - …, 2021 - pubmed.ncbi.nlm.nih.gov
Weight gain is a common side-effect of medications used to treat major depressive disorder
(MDD). We sought to estimate the frequency of weight gain for obesogenic medications …